Tag: China+1 strategy

China vs India Pharma Manufacturing: FDA Risks, Monitoring, and Supply Chain Reality

Explore the critical differences between China and India in pharmaceutical manufacturing. We analyze FDA monitoring data, regulatory risks, API supply chains, and why the 'China+1' strategy is reshaping global drug safety.